drugset / Trial / NCT07599761

A Phase 1 Study to Assess the Effect of Itraconazole on ABBV-722 in Healthy Adult Participants

NCT07599761

Phase 1 Recruiting 12 enrolled AbbVie
NaSingle-groupOpen-labelBasic science

Summary

The objective of this study is to assess the effect of repeated doses of itraconazole on the single dose pharmacokinetics (PK) of ABBV-722.

Timeline

Start
2026-05-05
Primary completion
2026-07
Completion
2026-07

Drugs

EvaluationDrugModalityDoseRoute
Subject ABBV-722 Unknown Oral
Subject Itraconazole Small molecule Oral

Indications

No indication recorded.